VIVXF (Avivagen) E10: $-0.10 (As of Jul. 2023)


What is Avivagen E10?

Avivagen VIVXF -99.00% E10 is $-0.10 as of Jul. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Avivagen's adjusted earnings per share data for the three months ended in Jul. 2023 was $-0.008. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.10 for the trailing ten years ended in Jul. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-07), Avivagen's current stock price is $0.0001. Avivagen's E10 for the quarter that ended in Jul. 2023 was $-0.10. Avivagen's Shiller PE Ratio of today is .


Avivagen  (OTCPK:VIVXF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Avivagen E10 Related Terms


Avivagen E10 Historical Data

* Premium members only.

The historical data trend for Avivagen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen E10 Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.28 -0.21 -0.19 -0.12 -0.11

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.11 -0.13 -0.10 -0.10

VIVXF vs DMKPQ, MJNE, ACORQ: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avivagen Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Avivagen's Shiller PE Ratio falls into.



Avivagen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Avivagen's adjusted earnings per share data for the three months ended in Jul. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jul. 2023 (Change)*Current CPI (Jul. 2023)
=-0.008/124.9144*124.9144
=-0.008

Current CPI (Jul. 2023) = 124.9144.

Avivagen Quarterly Data

per share eps CPI Adj_EPS
201310 -0.039 97.182 -0.050
201401 -0.027 97.261 -0.035
201404 -0.027 98.920 -0.034
201407 -0.028 99.315 -0.035
201410 -0.027 99.473 -0.034
201501 -0.025 98.209 -0.032
201504 -0.016 99.710 -0.020
201507 -0.016 100.579 -0.020
201510 -0.015 100.500 -0.019
201601 -0.021 100.184 -0.026
201604 -0.023 101.370 -0.028
201607 -0.031 101.844 -0.038
201610 -0.015 102.002 -0.018
201701 -0.030 102.318 -0.037
201704 -0.037 103.029 -0.045
201707 -0.032 103.029 -0.039
201710 -0.032 103.424 -0.039
201801 -0.032 104.056 -0.038
201804 -0.024 105.320 -0.028
201807 -0.023 106.110 -0.027
201810 -0.038 105.952 -0.045
201901 -0.023 105.557 -0.027
201904 -0.030 107.453 -0.035
201907 -0.031 108.243 -0.036
201910 -0.023 107.927 -0.027
202001 -0.031 108.085 -0.036
202004 -0.021 107.216 -0.024
202007 -0.015 108.401 -0.017
202010 -0.023 108.638 -0.026
202101 -0.024 109.192 -0.027
202104 -0.032 110.851 -0.036
202107 -0.016 112.431 -0.018
202110 -0.024 113.695 -0.026
202201 -0.024 114.801 -0.026
202204 -0.016 118.357 -0.017
202207 -0.023 120.964 -0.024
202210 -0.015 121.517 -0.015
202301 -0.007 121.596 -0.007
202304 -0.015 123.571 -0.015
202307 -0.008 124.914 -0.008

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.10 mean?
Avivagen (VIVXF) has a E10 of $-0.10 as of Jul. 2023. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Avivagen and its competitors.
Is Avivagen's E10 too high?
Avivagen's current E10 is $-0.10.
How does Avivagen's E10 compare to DMKPQ and MJNE?
Avivagen's E10 of $-0.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Avivagen and its competitors. Avivagen's current E10 is $-0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avivagen stock overvalued right now?
Avivagen (VIVXF) has a current E10 of $-0.10. The current E10 is $-0.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Avivagen (VIVXF), the current E10 is $-0.10 as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avivagen Business Description

Address 100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc OxC-beta technology is derived from Avivagen discoveries about Beta-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxCbeta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. Avivagen's OxC-beta Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters.